I was actually thinking the same thing this morning that we're already priced in to good results. Although I'm just trying to be conservative and looking at $11-13 per share if they do announce good results, even better if we see superiority.
The biggest hurdle is partnership, whether that is going to happen or not is the question since we do not have a sizable sales force come FDA approval (assuming this happens).
Keep holding, and hopefully by this time next year we will all be sipping on a nice cold Mai Thai on a sunny sandy beach somewhere.
Go MNKD!!
